Skip to content

Bicycle Therapeutics PLC Sustainability Reports

Bicycle Therapeutics plc is a clinical-stage biopharmaceutical company that develops a novel class of medicines called Bicycles, which are chemically synthesized constrained bicyclic peptides. These molecules are designed to selectively deliver therapeutic payloads, such as toxins or radioactive isotopes, directly to tumors while minimizing impact on healthy tissues.

Sector: Professional & technical services

Country: United Kingdom

Exchange: Nasdaq

LEI: 213800XKUI6R7GKC3E43

FIGI: BBG00P0YWQ97

5 reports from 2019 to 2024